-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

641.O2.6 641. CLL: Biology and Pathophysiology, excluding Therapy: Treatment Resistance and Prognosis Clinically Relevant Abstract

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Adult, Biological, Leukemia, antibodies, Coronaviruses, SARS-CoV-2/COVID-19, CLL, Diseases, Lymphoma (any), Therapies, CAR-Ts, Combinations, checkpoint inhibitors, cellular interactions, Non-Hodgkin Lymphoma, Biological Processes, white blood cells, Technology and Procedures, immune cells, epigenetics, Cell Lineage, immunotherapy, Study Population, Lymphoid Malignancies, Clinically relevant, genetic profiling, genomics, imaging, immune mechanism, flow cytometry, TKI, integrative -omics, NGS, RNA sequencing, pathogenesis, WGS, pathways, signal transduction
Sunday, December 6, 2020: 9:30 AM-11:00 AM
Sami Malek, MD, University of Michigan and Paolo Strati, MD, MD Anderson Cancer Center:
Malek: ABBV: Current equity holder in publicly-traded company; Astra Zeneca: Consultancy; EPZM: Current equity holder in publicly-traded company.
9:30 AM

Andrew Lipsky, MD1, Danny Luan, MPH2, Shirley Chen, BSc2*, Ronan Chaligne, PhD3*, Neville Dusaj, MS4*, Erica B Bhavsar, BS5*, Chelston Ang, MS6*, Anna S Nam, MD7, Federico Gaiti, PhD3*, Paulina Chamely, MSc3*, Nathaniel D. Omans, MS2*, Preeti Trisal, MS8*, Anita K Gandhi, PhD8, Kyu-Tae Kim, PhD9*, Rafael Schulman, BS10*, Joshua S. Schiffman, PhD11*, Franco Izzo, PhD3*, Gregory Mullokandov, MD, PhD5*, Chingiz Underbayev, MD, PhD12, Adrian Wiestner, MD, PhD12, John N. Allan, MD5, Richard R. Furman, MD13 and Dan A. Landau, MD, PhD3

1Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY
2Weill Cornell Medical College, New York, NY
3Meyer Cancer Center & Institute of Computational Biomedicine, Weill Cornell Medicine, New York, NY
4Weill Cornell/Rockefeller/Sloan Kettering Tri-Institutional MD-PhD Program, New York, NY
5Weill Cornell Medicine, New York, NY
6University of North Carolina School of Medicine, Chapel Hill, NC
7Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, NEW YORK, NY
8Bristol Myers Squibb, Summit, NJ
9Department of Physiology, Ajou University School of Medicine, Suwon, NY, Korea, Republic of (South)
10SUNY-Upstate Medical College, New York
11New York Genome Center, New York, NY
12Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
13Morton Coleman, M.D. Distinguished Professor of Medicine Weill Cornell Medical College, New York, NY

9:45 AM

Prajish Iyer, PhD1*, Lu Yang, PhD2*, Zhi-Zhang Yang, PhD3, Charla R. Secreto4*, Sutapa Sinha, PhD4, Neil E. Kay, MD4, Stephen M. Ansell, MD, PhD5, Lili Wang, MD, PhD6, Wei Ding, MD, PhD5 and Hyojin Kim, PhD5*

1Systems Biology Department, City of Hope National Medical Centre, Monrovia, CA
2Department of Systems Biology, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA
3Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN
4Division of Hematology, Mayo Clinic, Rochester, MN
5Mayo Clinic, Rochester, MN
6Department of Systems Biology, Beckman Research Institute, City of Hope, Monrovia, CA

10:00 AM

Ferran Nadeu1,2*, Romina Royo3*, Guillem Clot1,2*, Martí Duran-Ferrer1*, Alba Navarro, PhD1,2*, Silvia Martín1,2*, Junyan Lu4*, Thorsten Zenz5, Tycho Baumann6*, Pedro Jares1,2,6,7*, Xose S Puente, PhD2,8*, Jose Ignacio Martin-Subero1,2,7,9*, Julio Delgado, MD, PhD1,2,6* and Elias Campo, MD PhD1,2,6,7

1Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
2Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain
3Barcelona Supercomputing Center (BSC), Barcelona, Spain
4European Molecular Biology Laboratory (EMBL), Heidelberg, Germany
5Medical Oncology and Haematology, University Hospital Zürich, Zürich, Switzerland
6Hospital Clínic of Barcelona, Barcelona, Spain
7Universitat de Barcelona, Barcelona, Spain
8Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología, Universidad de Oviedo, Oviedo, Spain
9Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain

10:15 AM

McKensie Collins, BS, Weimin Kong, Ph.D.*, Inyoung Jung, BS*, Stefan M Lundh, BS* and J. Joseph Melenhorst, PhD

Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

10:30 AM

Charles C. Chu, PhD1, Jonathan J. Pinney, PhD2*, Sara K. Blick-Nitko, MS3*, Andrea M. Baran, MS1*, Derick R. Peterson, PhD1*, Hannah E. Whitehead2*, Raquel Izumi, PhD4, Veerendra Munugalavadla, PhD4, Paul M. Barr, MD1, Karl R. VanDerMeid, BS1*, Michael Rusty Elliott, PhD2,5* and Clive S. Zent, MD1

1Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
2Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY
3Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY
4Acerta Pharma, South San Francisco, CA
5Center for Cell Clearance and the Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA

*signifies non-member of ASH